נורדיטרופין 10 מג
novo nordisk ltd., israel - somatropin - תמיסה להזרקה - somatropin 10 mg / 1.5 ml - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (current height sds < - 2.5 and parental adjusted height sds < - 1) in short children born small for gestational age (sga) with a birth weight and/or length below - 2 sd who failed to show catch-up growth (hv sds < during the last year) by 4 years of age or later.children with short stature associated with noonan syndrome.adults: treatment of adults with hypothalamic-pituitary disease resulting from organic disease or pituitary tumors treated medically surgically or radiotherapy or patients with chilhood onset of g.h. deficiency.
גלוקגן היפוקיט 1 מג
novo nordisk ltd., israel - glucagon as hydrochloride - אבקה וממס להכנת תמיסה להזרקה - glucagon as hydrochloride 1 mg - glucagon - glucagon - treatment of severe hypoglycaemia reactions which may occur in the management of insulin treated persons with diabetes.
זולטופיי
novo nordisk ltd., israel - insulin degludec; liraglutide - תמיסה להזרקה - insulin degludec 100 u/ml; liraglutide 3.6 mg/ml - insulin degludec and liraglutide
טרגלודק 100 יחידותמיליליטר
novo nordisk ltd., israel - insulin degludec - תמיסה להזרקה - insulin degludec 100 u/ml - insulin degludec
טרגלודק 200 יחידותמיליליטר
novo nordisk ltd., israel - insulin degludec - תמיסה להזרקה - insulin degludec 200 u/ml - insulin degludec
לבמיר
novo nordisk ltd., israel - insulin detemir - תמיסה להזרקה - insulin detemir 100 u/ml - insulin detemir
אספרוקט 1000 יחבל
novo nordisk ltd., israel - turoctocog alfa pegol - אבקה וממס להכנת תמיסה להזרקה - turoctocog alfa pegol 1000 iu/vial
רפיקסיה 1000 יחבל
novo nordisk ltd., israel - nonacog beta pegol - אבקה וממס להכנת תמיסה להזרקה - nonacog beta pegol 1000 iu/vial - coagulation factor ix
סימולקט 20 מג
novartis israel ltd - basiliximab - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - basiliximab 20 mg/vial - basiliximab - basiliximab - prophylaxis of acute organ rejection in de novo renal transplantation in combination with cyclosporin and corticosteroid based immunosuppression
זולאייר 150 מג
novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.